For PD-L1 that is predominantly expressed in tumor cells, we also determined the score in tumor cells (PD-L1-TPS) and a combined score for PD-L1 in tumor and immune cells (PD-L1-CPS). This evidence concerns the gene CD274 and neoplasm.